In a pancreatic cancer in vivo mouse model, cells producing CXCL12 showed deficits in migration and poor metastatic potential in comparison to control cells producing no CXCL12 (Roy et al., 2014). This evidence concerns the gene CXCL12 and familial pancreatic carcinoma.